Eurazeo Secures €3 Billion for Capital V Fund
Deal News | Mar 05, 2025 | Eurazeo
Eurazeo, a leading private equity firm, has successfully closed its Eurazeo Capital V fund with commitments totaling approximately €3 billion, surpassing its target size. This achievement underscores the confidence investors have in Eurazeo's mid-large buyout strategy, which emphasizes growth in Tech-Enabled Business Services, Financial Services, and Healthcare & Life Sciences. The fund, which targets middle and upper-middle market businesses in Europe and North America, offers direct equity investments ranging from €200 to €350 million and provides co-investment opportunities. Supported by its predecessor's success, including significant exits from the EC-IV fund, EC-V already boasts substantial investment activity, having completed or announced six transactions in various sectors. The fund's strategy is managed by a dedicated team across multiple locations, reinforcing Eurazeo's commitment to fostering mid-market champions.
Sectors
- Private Equity
- Financial Services
- Healthcare & Life Sciences
Geography
- Europe – The fund focuses on businesses in the European mid-market, and Eurazeo is headquartered in Paris.
- North America – The fund targets mid-market businesses in this region, indicating its geographical investment scope.
Industry
- Private Equity – The article pertains to the closing of a private equity fund managed by Eurazeo, raising €3 billion to invest in mid-large buyouts.
- Financial Services – Eurazeo Capital V targets companies in this sector, reflecting its importance in their investment strategy.
- Healthcare & Life Sciences – This is one of the three sectors that Eurazeo's strategy focuses on, highlighting investment opportunities in the field.
Financials
- €3 billion – The total commitments for the Eurazeo Capital V fund.
- €200 million to €350 million – The expected range for direct equity investments by the EC-V fund.
- over €50 million – The commitment of the MLBO team into the Eurazeo Capital V fund.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Eurazeo | PE Firm | Company | A global investment firm specializing in private equity with a strong European presence, managing the Eurazeo Capital V fund. |
| Albingia | Portfolio Company | Company | A French insurance specialist that is part of the EC-IV fund, pending exit. |
| BMS | Portfolio Company | Company | A leading independent specialty insurance broker in the UK and US and a recent investment of the EC-V fund. |
| Mapal | Portfolio Company | Company | A Spanish company specializing in back-of-house software for the food service and hospitality market. |
| Eres | Portfolio Company | Company | A French independent player in employee profit sharing plans and retirement schemes. |
| Cranial Technologies | Portfolio Company | Company | A global leader in plagiocephaly treatments. |
| Sevetys | Portfolio Company | Company | A leading French veterinary clinic group. |
| Scaled Agile | Portfolio Company | Company | A company providing a reference method in business agility. |